Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CEO Sells $5,428,601.64 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 80,388 shares of the firm’s stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $67.53, for a total transaction of $5,428,601.64. Following the sale, the chief executive officer now owns 5,293,005 shares of the company’s stock, valued at approximately $357,436,627.65. The trade was a 1.50 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Tempus AI Price Performance

Shares of Tempus AI stock opened at $68.96 on Monday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business has a 50-day moving average of $44.49 and a 200 day moving average of $49.16. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wolfe Research started coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price target for the company. Needham & Company LLC reissued a “buy” rating and set a $56.00 target price on shares of Tempus AI in a research note on Tuesday, January 14th. Guggenheim started coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 price target on the stock. TD Cowen reiterated a “buy” rating and set a $74.00 price target (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Finally, Loop Capital reduced their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $58.55.

Institutional Trading of Tempus AI

Hedge funds have recently made changes to their positions in the business. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI in the third quarter valued at approximately $30,000. Geode Capital Management LLC boosted its position in Tempus AI by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after buying an additional 539 shares during the period. FNY Investment Advisers LLC acquired a new position in shares of Tempus AI in the fourth quarter worth $67,000. IFP Advisors Inc purchased a new stake in shares of Tempus AI during the fourth quarter worth $76,000. Finally, US Bancorp DE acquired a new stake in shares of Tempus AI in the fourth quarter valued at $80,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.